Related Experiment Video
Updated: Aug 24, 2025

06:08
Formulating and Characterizing an Exosome-based Dopamine Carrier System
Published on: April 4, 2022
3.2K
Coffee-Derived Exosome-Like Nanoparticles: Are They the Secret Heroes?
Murat Kantarcıoğlu1, Gülşen Yıldırım1, Pınar Akpınar Oktar1
1LÖSEV LÖSANTE Hospital, Ankara, Turkey.
Summary
Researchers identified edible plant-derived exosome-like nanoparticles in coffee. These coffee nanoparticles suppressed liver cancer cell proliferation, suggesting potential therapeutic benefits for liver diseases.
Area of Science:
- * Biochemistry and Nanotechnology
- * Cell Biology and Disease Mechanisms
Background:
- * Regular coffee consumption is linked to health benefits, including protection against liver and neurodegenerative diseases.
- * The exact mechanisms behind coffee's health benefits remain unclear.
- * Exosomes, cell-secreted nanoparticles, mediate intercellular communication and influence cellular metabolism.
Purpose of the Study:
- * To isolate and characterize edible plant-derived exosome-like nanoparticles from roasted hot coffee beverages.
- * To investigate the potential role of these nanoparticles in coffee's health benefits.
- * To explore the therapeutic potential of coffee-derived nanoparticles in liver diseases.
Main Methods:
- * Isolation of exosome-like nanoparticles using size exclusion chromatography and commercial kits.
- * Characterization via transmission electron microscopy and ultraviolet-visible spectrophotometry.
- * Assessment of proliferative effects on human liver cells (hepatic stellate and hepatocellular carcinoma) using MTT assay and RNA sequencing.
Main Results:
- * Identified round-shaped nanoparticles (40-100 nm) in coffee.
- * Coffee exosome-like nanoparticles significantly suppressed hepatocellular carcinoma cell proliferation.
- * RNA sequencing revealed 15 mature miRNAs, with KMT2C and ZNF773 highlighted as potential target genes.
Conclusions:
- * First identification of edible plant-derived exosome-like nanoparticles in coffee.
- * These nanoparticles show potential therapeutic effects for chronic liver diseases.
- * Further in vivo studies are recommended to confirm efficacy in disease models.

